Medical Research
(H81J)
IRS Verified
DX Registered
990 on File
THE FOUNDATION FOR AIDS RESEARCH
Financial strength (30%)
75/100
Reliability (20%)
55/100
Effectiveness (25%)
66/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$34.8M
Total Revenue
$33.3M
Total Expenses
$37.1M
Net Assets
71
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
72.3%
Fundraising Efficiency
560.3%
Operating Reserve
13.34x
Liability-to-Asset
36.1%
Revenue Diversification
138.5%
Executive Compensation
$3.2M
Compared with Peers
FY 2025
Compared with 35 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
72.3% | 82.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.8% | 9.0% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
18.9% | 0.2% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
560.3% | 1042.4% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
13.3 mo | 17.6 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
36.1% | 22.9% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
138.5% | 84.9% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
40.0% | 9.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
12.8% | 6.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
4.1% | 4.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $34.8M | $33.3M | $37.1M | 72.3% | 71 |
| 2024 | $24.8M | $29.6M | $33.8M | 69.7% | 75 |
| 2023 | $29.1M | $33.9M | $32.4M | 72.9% | 79 |
| 2022 | $31.4M | $28.0M | $35.1M | 68.4% | 73 |
| 2021 | $23.5M | $27.7M | N/A | — | 79 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.